United States Financial Markets News
Sign up for free!
Get instant access to all of our market news and analysis with our free REST API.
Search entities
Discover all 32,649 supported financial entities for United States financial markets here.
Latest news
Live response for past 24 hours
{
"meta": {
"found": 2655,
"returned": 10,
"limit": 10,
"page": 1
},
"data": [
{
"uuid": "3b2a77b3-d7ba-4205-a0e9-7090f124713d",
"title": "Earnings To Watch: Chugai Pharmaceutical Co Ltd (TSE:4519) Reports Q2 2025 Result",
"description": "Chugai Pharmaceutical Co Ltd (TSE:4519) is set to release its Q2 2025 earnings on Jul 24, 2025. The consensus estimate for Q2 2025 revenue is $326.77 billion, a",
"keywords": "GuruFocus, Article, News, GuruFocus News, TSE:4519",
"snippet": "Chugai Pharmaceutical Co Ltd (TSE:4519, Financial) is set to release its Q2 2025 earnings on Jul 24, 2025. The consensus estimate for Q2 2025 revenue is $326.77...",
"url": "https://www.gurufocus.com/news/2996994/earnings-to-watch-chugai-pharmaceutical-co-ltd-tse4519-reports-q2-2025-result",
"image_url": "https://static.gurufocus.com/logos/0C00000Y97.png?14",
"language": "en",
"published_at": "2025-07-23T13:17:34.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "CHGCY",
"name": "Chugai Pharmaceutical Co., Ltd.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 208.64005,
"sentiment_score": 0.056957,
"highlights": [
{
"highlight": "<em>Chugai</em> <em>Pharmaceutical</em> [+227 characters]",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Chugai</em> <em>Pharmaceutical</em> [+326 characters]",
"sentiment": 0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Chugai</em> <em>Pharmaceutical</em> [+260 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "After releasing the results, <em>Chugai<[+91 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Chugai</em> <em>Pharmaceutical</em> [+310 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+196 characters]",
"sentiment": 0.1027,
"highlighted_in": "main_text"
},
{
"highlight": "Earnings To Watch: <em>Chugai</em> <em>Pharmaceutical</em> <em>Co</em> <em>Ltd</em> (TSE:4519) Reports Q2 2025 Result",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "CHGCF",
"name": "Chugai Pharmaceutical Co., Ltd.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 208.59808,
"sentiment_score": 0.056957,
"highlights": [
{
"highlight": "<em>Chugai</em> <em>Pharmaceutical</em> [+227 characters]",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Chugai</em> <em>Pharmaceutical</em> [+326 characters]",
"sentiment": 0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Chugai</em> <em>Pharmaceutical</em> [+260 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "After releasing the results, <em>Chugai<[+91 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Chugai</em> <em>Pharmaceutical</em> [+310 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+196 characters]",
"sentiment": 0.1027,
"highlighted_in": "main_text"
},
{
"highlight": "Earnings To Watch: <em>Chugai</em> <em>Pharmaceutical</em> <em>Co</em> <em>Ltd</em> (TSE:4519) Reports Q2 2025 Result",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "32c18e13-0ec2-49ad-9126-6e367e81fc69",
"title": "BrainStorm Cell Therapeutics (BCLI) Downgraded by Maxim | BCLI Stock News",
"description": "Maxim Group has revised its rating for BrainStorm Cell Therapeutics (BCLI), moving it from a Buy to a Hold. This adjustment in the stock's rating reflects a shi",
"keywords": "GuruFocus, Article, News, GuruFocus News, BCLI",
"snippet": "Maxim Group has revised its rating for BrainStorm Cell Therapeutics (BCLI, Financial), moving it from a Buy to a Hold. This adjustment in the stock's rating ref...",
"url": "https://www.gurufocus.com/news/2996989/brainstorm-cell-therapeutics-bcli-downgraded-by-maxim-bcli-stock-news",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-07-23T13:15:27.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "BCLI",
"name": "Brainstorm Cell Therapeutics Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 132.125,
"sentiment_score": 0.2134,
"highlights": [
{
"highlight": "Maxim Group has revised its rating for <[+221 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+318 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+324 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "FDA has cleared <em>Brainstorm</em> <em>[+324 characters]",
"sentiment": 0.7184,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Brainstorm</em> <em>Cell</em> <em>Th[+170 characters]",
"sentiment": 0.5719,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Brainstorm</em> <em>Cell</em> <em>Th[+192 characters]",
"sentiment": 0.4767,
"highlighted_in": "main_text"
},
{
"highlight": "<em>BrainStorm</em> <em>Cell</em> <em>Therapeutics</em> (BCLI) Downgraded by Maxim | BCLI Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "bb4410fc-321b-4408-9418-f2982548bb51",
"title": "Plus Therapeutics (PSTV) Receives $1.6M Advance from CPRIT Grant | PSTV Stock News",
"description": "Plus Therapeutics (PSTV) has announced the receipt of a $1.6 million advance payment, which forms part of a larger $17.6 million grant awarded by the Cancer Pre",
"keywords": "GuruFocus, Article, News, GuruFocus News, PSTV",
"snippet": "Plus Therapeutics (PSTV, Financial) has announced the receipt of a $1.6 million advance payment, which forms part of a larger $17.6 million grant awarded by the...",
"url": "https://www.gurufocus.com/news/2996940/plus-therapeutics-pstv-receives-16m-advance-from-cprit-grant-pstv-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00000AUY.png?20",
"language": "en",
"published_at": "2025-07-23T13:02:19.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "PSTV",
"name": "Plus Therapeutics, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 62.0419,
"sentiment_score": 0.08766,
"highlights": [
{
"highlight": "<em>Plus</em> <em>Therapeutics</em> (PST[+197 characters]",
"sentiment": -0.0516,
"highlighted_in": "main_text"
},
{
"highlight": "Additionally, the grant supports the adv[+124 characters]",
"sentiment": 0.4019,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+297 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+284 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Plus</em> <em>Therapeutics</em> (PSTV) Receives $1.6M Advance from CPRIT Grant | PSTV Stock News",
"sentiment": 0.3612,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "8934cd18-b660-4eb5-93b3-2280a2140cb2",
"title": "Plus Therapeutics Announces $1.6 Million Advance Payment from CPRIT | PSTV Stock News",
"description": "Plus Therapeutics (PSTV) receives a $1.6 million advance from CPRIT as part of a $17.6 million grant. The funding supports the development of REYOBIQâ„¢",
"keywords": "GuruFocus, Article, News, GuruFocus News, PSTV",
"snippet": "Plus Therapeutics (PSTV, Financial) receives a $1.6 million advance from CPRIT as part of a $17.6 million grant.\n\nThe funding supports the development of REYOBI...",
"url": "https://www.gurufocus.com/news/2996748/plus-therapeutics-announces-16-million-advance-payment-from-cprit-pstv-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00000AUY.png?20",
"language": "en",
"published_at": "2025-07-23T12:46:30.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "PSTV",
"name": "Plus Therapeutics, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 57.618683,
"sentiment_score": 0.323975,
"highlights": [
{
"highlight": "<em>Plus</em> <em>Therapeutics</em> (PST[+335 characters]",
"sentiment": 0.6124,
"highlighted_in": "main_text"
},
{
"highlight": "Additionally, it will aid in the develop[+281 characters]",
"sentiment": 0.7351,
"highlighted_in": "main_text"
},
{
"highlight": "This strategic funding bolsters <em>Plus[+105 characters]",
"sentiment": -0.0516,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Plus</em> <em>Therapeutics</em> Announces $1.6 Million Advance Payment from CPRIT | PSTV Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "356f499d-0f33-44f0-b524-1b5369439393",
"title": "Sarepta Therapeutics (SRPT) Downgraded by B of A Securities | SRPT Stock News",
"description": "Sarepta Therapeutics (SRPT) faced a downgrade from B of A Securities, a move that has captured the attention of investors. On July 23, 2025, analyst Tazeen Ahma",
"keywords": "GuruFocus, Article, News, GuruFocus News, SRPT",
"snippet": "Sarepta Therapeutics (SRPT, Financial) faced a downgrade from B of A Securities, a move that has captured the attention of investors. On July 23, 2025, analyst ...",
"url": "https://www.gurufocus.com/news/2996711/sarepta-therapeutics-srpt-downgraded-by-b-of-a-securities-srpt-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00000AIQ.png?20",
"language": "en",
"published_at": "2025-07-23T12:32:44.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "SRPT",
"name": "Sarepta Therapeutics, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 92.16742,
"sentiment_score": 0.209971,
"highlights": [
{
"highlight": "<em>Sarepta</em> <em>Therapeutics</em> ([+269 characters]",
"sentiment": 0.5267,
"highlighted_in": "main_text"
},
{
"highlight": "This represents a 50% decrease in the ex[+315 characters]",
"sentiment": 0.1027,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+302 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+285 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+263 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+71 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Sarepta</em> <em>Therapeutics</em> (SRPT) Downgraded by B of A Securities | SRPT Stock News",
"sentiment": 0.296,
"highlighted_in": "title"
}
]
},
{
"symbol": "0L35.L",
"name": "Sarepta Therapeutics, Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 92.14561,
"sentiment_score": 0.209971,
"highlights": [
{
"highlight": "<em>Sarepta</em> <em>Therapeutics</em> ([+269 characters]",
"sentiment": 0.5267,
"highlighted_in": "main_text"
},
{
"highlight": "This represents a 50% decrease in the ex[+315 characters]",
"sentiment": 0.1027,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+302 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+285 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+263 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+71 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Sarepta</em> <em>Therapeutics</em> (SRPT) Downgraded by B of A Securities | SRPT Stock News",
"sentiment": 0.296,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "a0ab3b67-d43d-4e69-b29f-ffa77ec4e820",
"title": "Sarepta (SRPT) Downgraded by BofA with Lower Price Target | SRPT Stock News",
"description": "Bank of America analyst Tazeen Ahmad has revised their rating for Sarepta Therapeutics (SRPT), moving it from Neutral to Underperform. In addition, the analyst",
"keywords": "GuruFocus, Article, News, GuruFocus News, SRPT",
"snippet": "Bank of America analyst Tazeen Ahmad has revised their rating for Sarepta Therapeutics (SRPT, Financial), moving it from Neutral to Underperform. In addition, t...",
"url": "https://www.gurufocus.com/news/2996344/sarepta-srpt-downgraded-by-bofa-with-lower-price-target-srpt-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00000AIQ.png?20",
"language": "en",
"published_at": "2025-07-23T11:31:19.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "SRPT",
"name": "Sarepta Therapeutics, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 67.39829,
"sentiment_score": 0.408214,
"highlights": [
{
"highlight": "Bank of America analyst Tazeen Ahmad has[+249 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+302 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+285 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+263 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+302 characters]",
"sentiment": 0.6369,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Sarepta</em> <em>Th[+270 characters]",
"sentiment": 0.836,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Sarepta</em> <em>Therapeutics</em> <[+253 characters]",
"sentiment": 0.8402,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "0L35.L",
"name": "Sarepta Therapeutics, Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 67.38742,
"sentiment_score": 0.408214,
"highlights": [
{
"highlight": "Bank of America analyst Tazeen Ahmad has[+249 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+302 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+285 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+263 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+302 characters]",
"sentiment": 0.6369,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Sarepta</em> <em>Th[+270 characters]",
"sentiment": 0.836,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Sarepta</em> <em>Therapeutics</em> <[+253 characters]",
"sentiment": 0.8402,
"highlighted_in": "main_text"
}
]
}
]
}
]
},
{
"uuid": "ef613e51-628b-4eb4-bd7d-3bf2539821d0",
"title": "Oppenheimer Adjusts Enphase Energy (ENPH) Price Target Amid Revenue Forecasts | ENPH Stock News",
"description": "Oppenheimer has revised its price target for Enphase Energy (ENPH), lowering it from $86 to $77, reflecting adjusted estimates. Despite this adjustment, the fir",
"keywords": "GuruFocus, Article, News, GuruFocus News, ENPH",
"snippet": "Oppenheimer has revised its price target for Enphase Energy (ENPH, Financial), lowering it from $86 to $77, reflecting adjusted estimates. Despite this adjustme...",
"url": "https://www.gurufocus.com/news/2996986/oppenheimer-adjusts-enphase-energy-enph-price-target-amid-revenue-forecasts-enph-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00008TNA.png?20",
"language": "en",
"published_at": "2025-07-23T13:15:16.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "ENPH",
"name": "Enphase Energy, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 78.849556,
"sentiment_score": 0.103122,
"highlights": [
{
"highlight": "Oppenheimer has revised its price target[+206 characters]",
"sentiment": 0.0516,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+295 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+273 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+254 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+328 characters]",
"sentiment": -0.4767,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Enphase</em> <em>En[+318 characters]",
"sentiment": 0.6808,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Enphase</em> <em>Energy</em> <em>Inc[+194 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Enphase</em> <em>Energy</em> <em>Inc[+180 characters]",
"sentiment": 0.128,
"highlighted_in": "main_text"
},
{
"highlight": "Oppenheimer Adjusts <em>Enphase</em> <em>Energy</em> (ENPH) Price Target Amid Revenue Forecasts | ENPH Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "e8276489-fbe0-414c-b70d-5a9866b367b3",
"title": "Paccar (PCAR) Target Price Reduced by Analyst Amid Outlook Concerns | PCAR Stock News",
"description": "Morgan Stanley's analyst, Angel Castillo, has revised the price target for Paccar (PCAR), lowering it to $90 from $96. The decision comes after the company's se",
"keywords": "GuruFocus, Article, News, GuruFocus News, PCAR",
"snippet": "Morgan Stanley's analyst, Angel Castillo, has revised the price target for Paccar (PCAR, Financial), lowering it to $90 from $96. The decision comes after the c...",
"url": "https://www.gurufocus.com/news/2996578/paccar-pcar-target-price-reduced-by-analyst-amid-outlook-concerns-pcar-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00000C2J.png?20",
"language": "en",
"published_at": "2025-07-23T12:15:46.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "PAE.DE",
"name": "PACCAR Inc.",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Industrials",
"match_score": 58.064125,
"sentiment_score": 0.26957,
"highlights": [
{
"highlight": "Morgan Stanley's analyst, Angel Castillo[+237 characters]",
"sentiment": 0.3506,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+279 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+326 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+238 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+290 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>PACCAR</em> Parts Revenue: Record qu[+306 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>PACCAR</em> Parts Gross Margin: 30% [+271 characters]",
"sentiment": -0.4767,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>PACCAR</em> <em>Inc[+322 characters]",
"sentiment": 0.9545,
"highlighted_in": "main_text"
},
{
"highlight": "<em>PACCAR</em> <em>Inc</em> (PCAR) deli[+326 characters]",
"sentiment": 0.872,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Paccar</em> (PCAR) Target Price Reduced by Analyst Amid Outlook Concerns | PCAR Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "PCAR",
"name": "PACCAR Inc",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Industrials",
"match_score": 58.051537,
"sentiment_score": 0.26957,
"highlights": [
{
"highlight": "Morgan Stanley's analyst, Angel Castillo[+237 characters]",
"sentiment": 0.3506,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+279 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+326 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+238 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+290 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>PACCAR</em> Parts Revenue: Record qu[+306 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>PACCAR</em> Parts Gross Margin: 30% [+271 characters]",
"sentiment": -0.4767,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>PACCAR</em> <em>Inc[+322 characters]",
"sentiment": 0.9545,
"highlighted_in": "main_text"
},
{
"highlight": "<em>PACCAR</em> <em>Inc</em> (PCAR) deli[+326 characters]",
"sentiment": 0.872,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Paccar</em> (PCAR) Target Price Reduced by Analyst Amid Outlook Concerns | PCAR Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "0KET.L",
"name": "PACCAR Inc",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 58.021046,
"sentiment_score": 0.26957,
"highlights": [
{
"highlight": "Morgan Stanley's analyst, Angel Castillo[+237 characters]",
"sentiment": 0.3506,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+279 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+326 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+238 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+290 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>PACCAR</em> Parts Revenue: Record qu[+306 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>PACCAR</em> Parts Gross Margin: 30% [+271 characters]",
"sentiment": -0.4767,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>PACCAR</em> <em>Inc[+322 characters]",
"sentiment": 0.9545,
"highlighted_in": "main_text"
},
{
"highlight": "<em>PACCAR</em> <em>Inc</em> (PCAR) deli[+326 characters]",
"sentiment": 0.872,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Paccar</em> (PCAR) Target Price Reduced by Analyst Amid Outlook Concerns | PCAR Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "6dc252a3-e2b8-4acd-848f-00060534cb0a",
"title": "Aeva Technologies Inc (AEVA) Revolutionizes Airport Operations with 4D LiDAR Deployment at Tampa International Airport | AEVA stock news",
"description": "Summary Aeva Technologies Inc (AEVA), a pioneer in next-generation sensing and perception systems, announced the deployment of its 4D LiDAR technology at Tampa",
"keywords": "GuruFocus, Article, News, GuruFocus News, AEVA",
"snippet": "Summary\n\nAeva Technologies Inc (AEVA, Financial), a pioneer in next-generation sensing and perception systems, announced the deployment of its 4D LiDAR technolo...",
"url": "https://www.gurufocus.com/news/2996983/aeva-technologies-inc-aeva-revolutionizes-airport-operations-with-4d-lidar-deployment-at-tampa-international-airport-aeva-stock-news",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-07-23T13:12:19.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "AEVA",
"name": "Aeva Technologies, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "N/A",
"match_score": 164.13483,
"sentiment_score": 0.487075,
"highlights": [
{
"highlight": "Summary\n\n<em>Aeva</em> <em>Technologies<[+344 characters]",
"sentiment": 0.836,
"highlighted_in": "main_text"
},
{
"highlight": "Negative Aspects\n\nAs an early-stage comp[+229 characters]",
"sentiment": 0.4215,
"highlighted_in": "main_text"
},
{
"highlight": "The partnership with Sotereon.AI positio[+252 characters]",
"sentiment": 0.6908,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Aeva</em> <em>Technologies</em> <em>Inc</em> (<em>AEVA</em>) Revolutionizes Airport Operations with 4D LiDAR Deployment at Tampa International Airport | <em>AEVA</em> stock news",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "e8b5f5c4-a2e8-4564-a28f-f1ee76d499a4",
"title": "Ascentage Pharma Group International to Participate in BTIG Virtual Biotechnology Conference | AAPG stock news",
"description": "Summary Ascentage Pharma Group International (AAPG) announced on July 23, 2025, that its management team will participate in the BTIG Virtual Biotechnology Conf",
"keywords": "GuruFocus, Article, News, GuruFocus News, AAPG",
"snippet": "Summary\n\nAscentage Pharma Group International (AAPG, Financial) announced on July 23, 2025, that its management team will participate in the BTIG Virtual Biotec...",
"url": "https://www.gurufocus.com/news/2996981/ascentage-pharma-group-international-to-participate-in-btig-virtual-biotechnology-conference-aapg-stock-news",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-07-23T13:11:25.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "ASPHF",
"name": "Ascentage Pharma Group International",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 191.6641,
"sentiment_score": 0,
"highlights": [
{
"highlight": "Summary\n\n<em>Ascentage</em> <em>Pharma</[+206 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Ascentage</em> <em>Pharma</em> <em>Group</em> <em>International</em> to Participate in BTIG Virtual Biotechnology Conference | AAPG stock news",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "d9632c27-a587-4f8d-af16-005bdd3b06db",
"title": "BD Announces First Pharma-Sponsored Clinical Trial Using BD Libertas™ Wearable Injector Technology for Biologic Drugs | BDX Stock News",
"description": "100% of study participants indicated likely future use of BD Libertasâ„¢ Wearable Injector. The device enables conversion from hospital-based infusions",
"keywords": "GuruFocus, Article, News, GuruFocus News, BDX",
"snippet": "100% of study participants indicated likely future use of BD Libertas™ Wearable Injector.\n\nThe device enables conversion from hospital-based infusions to conv...",
"url": "https://www.gurufocus.com/news/2996608/bd-announces-first-pharmasponsored-clinical-trial-using-bd-libertas-wearable-injector-technology-for-biologic-drugs-bdx-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C000006VR.png?20",
"language": "en",
"published_at": "2025-07-23T12:17:47.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "BDX",
"name": "Becton, Dickinson and Company",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 46.658035,
"sentiment_score": 0,
"highlights": [
{
"highlight": "., July 23, 2025 /PRNewswire/ -- BD (<em[+227 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "BDXB",
"name": "Becton, Dickinson and Company",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 46.658047,
"sentiment_score": 0,
"highlights": [
{
"highlight": "., July 23, 2025 /PRNewswire/ -- BD (<em[+227 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "BDX.MX",
"name": "Becton, Dickinson and Company",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 46.65593,
"sentiment_score": 0,
"highlights": [
{
"highlight": "., July 23, 2025 /PRNewswire/ -- BD (<em[+227 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "0R19.L",
"name": "Becton, Dickinson and Company",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 46.655064,
"sentiment_score": 0,
"highlights": [
{
"highlight": "., July 23, 2025 /PRNewswire/ -- BD (<em[+227 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
}
]
}
]
},
{
"uuid": "187fdc59-6baa-4455-8c49-5ae679173202",
"title": "Lantheus Holdings Inc (LNTH) Announces Upcoming Q2 2025 Financial Results Conference Call | LNTH stock news",
"description": "Summary Lantheus Holdings Inc (LNTH), a leading radiopharmaceutical-focused company, announced it will host a conference call and webcast on August 6, 2025, at",
"keywords": "GuruFocus, Article, News, GuruFocus News, LNTH",
"snippet": "Summary\n\nLantheus Holdings Inc (LNTH, Financial), a leading radiopharmaceutical-focused company, announced it will host a conference call and webcast on August ...",
"url": "https://www.gurufocus.com/news/2996965/lantheus-holdings-inc-lnth-announces-upcoming-q2-2025-financial-results-conference-call-lnth-stock-news",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-07-23T13:06:03.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "LNTH",
"name": "Lantheus Holdings, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 114.94703,
"sentiment_score": 0.35925,
"highlights": [
{
"highlight": "Summary\n\n<em>Lantheus</em> <em>Holdings<[+287 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Aspects\n\n<em>Lantheus</em> <em>[+309 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "Financial Analyst Perspective\n\nFrom a fi[+189 characters]",
"sentiment": 0.5574,
"highlighted_in": "main_text"
},
{
"highlight": "Market Research Analyst Perspective\n\nAs [+297 characters]",
"sentiment": 0.8402,
"highlighted_in": "main_text"
},
{
"highlight": "FAQ\n\nQ: When is the <em>Lantheus</em> <e[+323 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Lantheus</em> <em>Holdings</em> <em>Inc</em> (LNTH) Announces Upcoming Q2 2025 Financial Results Conference Call | LNTH stock news",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "45b1b56a-f5d3-4ce6-88e8-ef5ac3400d67",
"title": "Lantheus to Host Second Quarter 2025 Earnings Conference Call and Webcast on August 6, 2025, at 8:00 a.m. Eastern Time",
"description": "BEDFORD, Mass., July 23, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the ”Company”) ( LNTH) today announced that it will host a conference call and",
"keywords": "GuruFocus, Article, News, Marketwired, LNTH",
"snippet": "BEDFORD, Mass., July 23, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) ( LNTH) today announced that it will host a conference call and we...",
"url": "https://www.gurufocus.com/news/2996843/lantheus-to-host-second-quarter-2025-earnings-conference-call-and-webcast-on-august-6-2025-at-800-am-eastern-time",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-07-23T13:00:08.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "LNTH",
"name": "Lantheus Holdings, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 46.788025,
"sentiment_score": 0,
"highlights": [
{
"highlight": "., July 23, 2025 (GLOBE NEWSWIRE) -- <em[+280 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
}
]
},
{
"uuid": "2c14ab71-28ea-46d0-900b-f656e8990d55",
"title": "Lantheus to Host Second Quarter 2025 Earnings Conference Call and Webcast on August 6, 2025, at 8:00 a.m. Eastern Time",
"description": "BEDFORD, Mass., July 23, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the 'Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Wednesday, August 6, 2025, to discuss its financial results and provide a business update for the second quarter of 2025.",
"keywords": "Lantheus, to, Host, Second, Quarter, 2025, Earnings, Conference, Call, and, Webcast, on, August, 6, , 2025, , at, 8:00, a.m., Eastern, Time",
"snippet": "BEDFORD, Mass., July 23, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the \"Company”) (NASDAQ: LNTH) today announced that it will host a conference call a...",
"url": "https://www.manilatimes.net/2025/07/23/tmt-newswire/globenewswire/lantheus-to-host-second-quarter-2025-earnings-conference-call-and-webcast-on-august-6-2025-at-800-am-eastern-time/2154690",
"image_url": "https://www.manilatimes.net/manilatimes/uploads/images/2025/07/23/687850.png",
"language": "en",
"published_at": "2025-07-23T12:19:08.000000Z",
"source": "manilatimes.net",
"relevance_score": null,
"entities": [
{
"symbol": "LNTH",
"name": "Lantheus Holdings, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 70.208916,
"sentiment_score": 0,
"highlights": [
{
"highlight": "., July 23, 2025 (GLOBE NEWSWIRE) -- <em[+303 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
}
]
}
]
},
{
"uuid": "ba7e5ad2-dfb6-4687-a7ed-5377cafda469",
"title": "PRG Updates FY25 Revenue and EBITDA Projections | PRG Stock News",
"description": "PRG has refined its financial projections for the fiscal year 2025, adjusting its revenue expectations to a range of $2.45 billion to $2.5 billion from the prev",
"keywords": "GuruFocus, Article, News, GuruFocus News, PRG",
"snippet": "PRG has refined its financial projections for the fiscal year 2025, adjusting its revenue expectations to a range of $2.45 billion to $2.5 billion from the prev...",
"url": "https://www.gurufocus.com/news/2996957/prg-updates-fy25-revenue-and-ebitda-projections-prg-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C0000096D.png?20",
"language": "en",
"published_at": "2025-07-23T13:04:20.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "PRG",
"name": "PROG Holdings, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Industrials",
"match_score": 50.797325,
"sentiment_score": 0.27545,
"highlights": [
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+292 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+274 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+251 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+302 characters]",
"sentiment": 0.5574,
"highlighted_in": "main_text"
}
]
}
],
"similar": [
{
"uuid": "0501c0c7-099e-4612-bd98-01d5f149826e",
"title": "PRG Projects Q3 Revenue and Adjusted EBITDA Expectations | PRG Stock News",
"description": "For the third quarter, the company is projecting revenue to be in the range of $580 million to $595 million. This estimate aligns closely with market expectatio",
"keywords": "GuruFocus, Article, News, GuruFocus News, PRG",
"snippet": "For the third quarter, the company is projecting revenue to be in the range of $580 million to $595 million. This estimate aligns closely with market expectatio...",
"url": "https://www.gurufocus.com/news/2996954/prg-projects-q3-revenue-and-adjusted-ebitda-expectations-prg-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C0000096D.png?20",
"language": "en",
"published_at": "2025-07-23T13:04:01.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "PRG",
"name": "PROG Holdings, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Industrials",
"match_score": 50.797325,
"sentiment_score": 0.27545,
"highlights": [
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+292 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+274 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+251 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+302 characters]",
"sentiment": 0.5574,
"highlighted_in": "main_text"
}
]
}
]
},
{
"uuid": "0a80c8b0-7156-439d-80a4-e4588b28d682",
"title": "Rogers (RCI) Projects Growth in Media Revenue and Service Earnings | RCI Stock News",
"description": "Rogers (RCI) anticipates its 2025 pro forma Media revenue, including contributions from MLSE, to be around C$3.9 billion, with an adjusted EBITDA close to C$250",
"keywords": "GuruFocus, Article, News, GuruFocus News, RCI",
"snippet": "Rogers (RCI, Financial) anticipates its 2025 pro forma Media revenue, including contributions from MLSE, to be around C$3.9 billion, with an adjusted EBITDA clo...",
"url": "https://www.gurufocus.com/news/2996675/rogers-rci-projects-growth-in-media-revenue-and-service-earnings-rci-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C000008U7.png?20",
"language": "en",
"published_at": "2025-07-23T12:30:35.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "RCI",
"name": "Rogers Communications Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Communication Services",
"match_score": 46.802147,
"sentiment_score": 0.374729,
"highlights": [
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+301 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+291 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+259 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+295 characters]",
"sentiment": 0.9081,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Rogers</em> <em>Com[+265 characters]",
"sentiment": 0.91,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Rogers</em> <em>Communications</em> [+293 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Rogers</em> <em>Communications</em> [+180 characters]",
"sentiment": -0.25,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "RCIAF",
"name": "Rogers Communications Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Communication Services",
"match_score": 46.80115,
"sentiment_score": 0.374729,
"highlights": [
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+301 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+291 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+259 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+295 characters]",
"sentiment": 0.9081,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Rogers</em> <em>Com[+265 characters]",
"sentiment": 0.91,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Rogers</em> <em>Communications</em> [+293 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Rogers</em> <em>Communications</em> [+180 characters]",
"sentiment": -0.25,
"highlighted_in": "main_text"
}
]
}
]
},
{
"uuid": "573ba45b-9ea4-4e59-890b-56dacfc04c96",
"title": "Hilton (HLT) Predicts Q3 Revenue Per Room Slight Fluctuation | HLT Stock News",
"description": "Hilton Worldwide Holdings Inc. (HLT) anticipates that its system-wide comparable revenue per available room (RevPAR) for the third quarter may remain flat or sl",
"keywords": "GuruFocus, Article, News, GuruFocus News, HLT",
"snippet": "Hilton Worldwide Holdings Inc. (HLT, Financial) anticipates that its system-wide comparable revenue per available room (RevPAR) for the third quarter may remain...",
"url": "https://www.gurufocus.com/news/2996339/hilton-hlt-predicts-q3-revenue-per-room-slight-fluctuation-hlt-stock-news",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-07-23T11:31:13.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "HLT",
"name": "Hilton Worldwide Holdings Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 68.98399,
"sentiment_score": 0.353738,
"highlights": [
{
"highlight": "<em>Hilton</em> <em>Worldwide</em> <em>H[+255 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+319 characters]",
"sentiment": -0.4767,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+317 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+275 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+291 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Hilton</em> <em>Wor[+284 characters]",
"sentiment": 0.8591,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Hilton</em> <em>Worldwide</em> <em>H[+269 characters]",
"sentiment": 0.8625,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Hilton</em> <em>Worldwide</em> <em>H[+187 characters]",
"sentiment": 0.8271,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "HLT.MX",
"name": "Hilton Worldwide Holdings Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 68.98215,
"sentiment_score": 0.353738,
"highlights": [
{
"highlight": "<em>Hilton</em> <em>Worldwide</em> <em>H[+255 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+319 characters]",
"sentiment": -0.4767,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+317 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+275 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+291 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Hilton</em> <em>Wor[+284 characters]",
"sentiment": 0.8591,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Hilton</em> <em>Worldwide</em> <em>H[+269 characters]",
"sentiment": 0.8625,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Hilton</em> <em>Worldwide</em> <em>H[+187 characters]",
"sentiment": 0.8271,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "0J5I.L",
"name": "Hilton Worldwide Holdings Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 68.98096,
"sentiment_score": 0.353738,
"highlights": [
{
"highlight": "<em>Hilton</em> <em>Worldwide</em> <em>H[+255 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+319 characters]",
"sentiment": -0.4767,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+317 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+275 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+291 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Hilton</em> <em>Wor[+284 characters]",
"sentiment": 0.8591,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Hilton</em> <em>Worldwide</em> <em>H[+269 characters]",
"sentiment": 0.8625,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Hilton</em> <em>Worldwide</em> <em>H[+187 characters]",
"sentiment": 0.8271,
"highlighted_in": "main_text"
}
]
}
]
}
]
},
{
"uuid": "45034e17-e1fe-4b79-9891-f1c65cc3da50",
"title": "MP: Baird Increases Price Target Amid Department of Defense Partnership | MP Stock News",
"description": "Baird analyst Ben Kallo has increased the price target for MP Materials (MP) from $52 to $69, while maintaining an Outperform rating. This adjustment comes in t",
"keywords": "GuruFocus, Article, News, GuruFocus News, MP",
"snippet": "Baird analyst Ben Kallo has increased the price target for MP Materials (MP, Financial) from $52 to $69, while maintaining an Outperform rating. This adjustment...",
"url": "https://www.gurufocus.com/news/2996951/mp-baird-increases-price-target-amid-department-of-defense-partnership-mp-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C0000BZNA.png?20",
"language": "en",
"published_at": "2025-07-23T13:03:46.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "MP",
"name": "MP Materials Corp.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Basic Materials",
"match_score": 48.158733,
"sentiment_score": 0.19992,
"highlights": [
{
"highlight": "Baird analyst Ben Kallo has increased th[+332 characters]",
"sentiment": 0.7184,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+293 characters]",
"sentiment": -0.4767,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+273 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+252 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+62 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "MP-WT",
"name": "MP Materials Corp.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "N/A",
"match_score": 48.158527,
"sentiment_score": 0.19992,
"highlights": [
{
"highlight": "Baird analyst Ben Kallo has increased th[+332 characters]",
"sentiment": 0.7184,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+293 characters]",
"sentiment": -0.4767,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+273 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+252 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+62 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "f2bb8233-a910-4ce9-a345-ffdd507200a3",
"title": "Rogers Communications Inc (RCI) Declares Quarterly Dividend for October 2025 | RCI stock news",
"description": "Summary Rogers Communications Inc (RCI), a leading communications and entertainment company in Canada, has announced a quarterly dividend of 50 cents per share",
"keywords": "GuruFocus, Article, News, GuruFocus News, RCI",
"snippet": "Summary\n\nRogers Communications Inc (RCI, Financial), a leading communications and entertainment company in Canada, has announced a quarterly dividend of 50 cent...",
"url": "https://www.gurufocus.com/news/2996949/rogers-communications-inc-rci-declares-quarterly-dividend-for-october-2025-rci-stock-news",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-07-23T13:03:31.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "RCIAF",
"name": "Rogers Communications Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Communication Services",
"match_score": 119.54828,
"sentiment_score": 0.63122,
"highlights": [
{
"highlight": "Summary\n\n<em>Rogers</em> <em>Communicati[+328 characters]",
"sentiment": 0.7351,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Aspects\n\n<em>Rogers</em> <em>Co[+229 characters]",
"sentiment": 0.9081,
"highlighted_in": "main_text"
},
{
"highlight": "Financial Analyst Perspective\n\nFrom a fi[+238 characters]",
"sentiment": 0.8126,
"highlighted_in": "main_text"
},
{
"highlight": "Market Research Analyst Perspective\n\nAs [+224 characters]",
"sentiment": 0.7003,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Rogers</em> <em>Communications</em> <em>Inc</em> (RCI) Declares Quarterly Dividend for October 2025 | RCI stock news",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "abad30d6-adcf-4888-b67e-ec8a7ac788b4",
"title": "Rogers Communications Declares 50 Cents per Share Quarterly Dividend | RCI Stock News",
"description": "Rogers Communications (RCI) declares a quarterly dividend of $0.50 per share. The dividend applies to both Class A Voting and Class B Non-Voting shares.",
"keywords": "GuruFocus, Article, News, GuruFocus News, RCI",
"snippet": "Rogers Communications (RCI, Financial) declares a quarterly dividend of $0.50 per share.\n\nThe dividend applies to both Class A Voting and Class B Non-Voting sha...",
"url": "https://www.gurufocus.com/news/2996638/rogers-communications-declares-50-cents-per-share-quarterly-dividend-rci-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C000008U7.png?20",
"language": "en",
"published_at": "2025-07-23T12:19:28.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "RCI",
"name": "Rogers Communications Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Communication Services",
"match_score": 74.38438,
"sentiment_score": 0.605667,
"highlights": [
{
"highlight": "<em>Rogers</em> <em>Communications</em> [+342 characters]",
"sentiment": 0.6808,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Rogers</em> <em>Communications</em> [+287 characters]",
"sentiment": 0.8402,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Rogers</em> <em>Communications</em> Declares 50 Cents per Share Quarterly Dividend | RCI Stock News",
"sentiment": 0.296,
"highlighted_in": "title"
}
]
},
{
"symbol": "RCIAF",
"name": "Rogers Communications Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Communication Services",
"match_score": 74.37233,
"sentiment_score": 0.605667,
"highlights": [
{
"highlight": "<em>Rogers</em> <em>Communications</em> [+342 characters]",
"sentiment": 0.6808,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Rogers</em> <em>Communications</em> [+287 characters]",
"sentiment": 0.8402,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Rogers</em> <em>Communications</em> Declares 50 Cents per Share Quarterly Dividend | RCI Stock News",
"sentiment": 0.296,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "18db03c8-e31c-4f67-a08f-829193a088f0",
"title": "PROCEPT BioRobotics Corp (PRCT) Achieves Milestone in Prostate Cancer Treatment with Aquablation Therapy | PRCT stock news",
"description": "Summary On July 23, 2025, PROCEPT BioRobotics Corp (PRCT), a leader in surgical robotics focused on urology solutions, announced a significant achievement in th",
"keywords": "GuruFocus, Article, News, GuruFocus News, PRCT",
"snippet": "Summary\n\nOn July 23, 2025, PROCEPT BioRobotics Corp (PRCT, Financial), a leader in surgical robotics focused on urology solutions, announced a significant achie...",
"url": "https://www.gurufocus.com/news/2996942/procept-biorobotics-corp-prct-achieves-milestone-in-prostate-cancer-treatment-with-aquablation-therapy-prct-stock-news",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-07-23T13:02:54.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "PRCT",
"name": "PROCEPT BioRobotics Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 118.35313,
"sentiment_score": -0.0442,
"highlights": [
{
"highlight": "Summary\n\nOn July 23, 2025, <em>PROCEPT</[+192 characters]",
"sentiment": -0.0772,
"highlighted_in": "main_text"
},
{
"highlight": "Financial Analyst Perspective\n\nFrom a fi[+179 characters]",
"sentiment": 0.5859,
"highlighted_in": "main_text"
},
{
"highlight": "The trial's focus on harm reduction and [+278 characters]",
"sentiment": -0.0258,
"highlighted_in": "main_text"
},
{
"highlight": "<em>PROCEPT</em> <em>BioRobotics</em> Corp (<em>PRCT</em>) Achieves Milestone in Prostate Cancer Treatment with Aquablation Therapy | <em>PRCT</em> stock news",
"sentiment": -0.6597,
"highlighted_in": "title"
}
]
}
],
"similar": []
}
]
}
Sentiment
Live response for past 24 hours
{
"meta": {
"returned": 1,
"limit": 10
},
"data": [
{
"key": "us",
"total_documents": 4141,
"sentiment_avg": 0.3086501602942837
}
]
}
Other details
Entity count
- 32,649